Uncoupling protein-3 content is decreased in peripheral skeletal muscle of patients with COPD

European Respiratory Journal

Volumn 22, Issue 1, 2003, Pages 88-93

  Gosker, H R ^a   Schrauwen, P ^a   Hesselink, M K C ^a   Schaart, G ^a   van der Vusse, G J ^b   Wouters, E F M ^a   Schols, A M W J ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease; Energy metabolism; Muscle fibre types; Peripheral skeletal muscle; Uncoupling protein 3

Indexed keywords

CELL MARKER; CYTOCHROME C; UNCOUPLING PROTEIN 3;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BICYCLE ERGOMETER; BREATHING MECHANICS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENERGY METABOLISM; FEMALE; FORCED EXPIRATORY VOLUME; GLYCOLYSIS; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE METABOLISM; MUSCLE MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN CONTENT; REGULATORY MECHANISM; SKELETAL MUSCLE; VASTUS LATERALIS MUSCLE; WESTERN BLOTTING;

AGED; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CARRIER PROTEINS; CASE-CONTROL STUDIES; ENERGY METABOLISM; EXERCISE TEST; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ION CHANNELS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 0041810507     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.03.00089802     Document Type: Article

References (46)

1. Baarends EM, Schols AM, Pannemans DL, Westerterp KR, Wouters EF. Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 155: 549-554.
2. Hugh O, Frascarolo P, Schutz Y, Jequier E, Leuenberger P, Fitting JW. Diet-induced thermogenesis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 148: 1479-1483.
3. Schols AMWJ, Fredrix EW, Soeters PB, Westerterp KR, Wouters EF. Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1991; 54: 983-987.
4. Creutzberg EC, Schols AMWJ, Bothmer-Quaedvlieg FCM, Wouters EFM. Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function. Eur J Clin Nutr 1998; 52: 396-401.
5. Baarends EM, Schols AM, Westerterp KR, Wouters EF. Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD. Thorax 1997; 52: 780-785.
6. Baarends EM, Schols AM, Akkermans MA, Wouters EF. Decreased mechanical efficiency in clinically stable patients with COPD. Thorax 1997; 52: 981-986.
7. Sala E, Roca J, Marrades RM, et al. Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 1726-1734.
8. Gosker HR, Wouters EF, van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 2000; 71: 1033-1047.
9. Ricquier D, Bouillaud F. The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP. Biochem J 2000; 345: 161-179.
10. Schrauwen P, Walder K, Ravussin E. Human uncoupling proteins and obesity. Obes Res 1999; 7: 97-105.
11. Boss O, Samec S, Paoloni-Giacobino A, et al. Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression. FEBS Lett 1997; 408: 39-42.
12. Bouchard C, Perusse L, Chagnon YC, Warden C, Ricquier D. Linkage between markers in the vicinity of the uncoupling protein 2 gene and resting metabolic rate in humans. Hum Mol Genet 1997; 6: 1887-1889.
13. Schrauwen P, Xia J, Bogardus C, Pratley RE, Ravussin E. Skeletal muscle uncoupling protein 3 expression is a determinant of energy expenditure in Pima Indians. Diabetes 1999; 48: 146-149.
14. Schrauwen P, Troost FJ, Xia J, Ravussin E, Saris WH. Skeletal muscle UCP2 and UCP3 expression in trained and untrained male subjects. Int J Obes Relat Metab Disord 1999; 23: 966-972.
15. Schrauwen P, Schaart G, Saris WH, et al. The effect of weight reduction on skeletal muscle UCP2 and UCP3 mRNA expression and UCP3 protein content in type II diabetic subjects. Diabetologia 2000; 43: 1408-1416.
16. Vidal-Puig A, Rosenbaum M, Considine RC, et al. Effects of obesity and stable weight reduction on UCP2 and UCP3 gene expression in humans. Obes Res 1999; 7: 133-140.
17. Clapham JC, Arch JR, Chapman H, et al. Mice over-expressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean. Nature 2000; 406: 415-418.
18. Millet L, Vidal H, Andreelli F, et al. Increased uncoupling protein-2 and -3 mRNA expression during fasting in obese and lean humans. J Clin Invest 1997; 100: 2665-2670.
19. Gong DW, Monemdjou S, Gavrilova O, et al. Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3. J Biol Chem 2000; 275: 16251-16257.
20. Hesselink MK, Keizer HA, Borghouts LB, et al. Protein expression of UCP3 differs between human type 1, type 2a, and type 2b fibers. FASEB J 2001; 15: 1071-1073.
21. ATS. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152: S77-S121.
22. Quanjer P, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Standardized lung function testing. Eur Respir J 1993; 6: 5-40.
23. Engelen MPKJ, Schols AMWJ, Heidendal GAK, Wouters EFM. Dual-energy X-ray absorptiometry in the clinical evaluation of body composition and bone mineral density in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 1998; 68: 1298-1303.
24. VanItallie TB, Yang MU, Heymsfield SB, Funk RC, Boileau RA. Height-normalized indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status. Am J Clin Nutr 1990; 52: 953-959.
25. Schols AM, Schoffelen PF, Ceulemans H, Wouters EF, Saris WH. Measurement of resting energy expenditure in patients with chronic obstructive pulmonary disease in a clinical setting. JPEN J Parenter Enteral Nutr 1992; 16: 364-368.
26. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. 1949. Nutrition 1990; 6: 213-221.
27. Franssen FME, Wouters EFM, Baarends EM, Akkermans MA, Schols AMWJ. Arm mechanical efficiency and arm exercise capacity are relatively preserved in chronic obstructive pulmonary disease. Med Sci Sports Exerc 2002; 34: 1570-1576.
28. Bergstrom L. Muscle electrolytes in man. Determination by neutron activation analysis on needle biopsy specimens. A study on normal subjects, kidney patients, and patients with chronic diarrhea. Scand J Clin Lab Invest 1962; 68: 1-110.
29. Gosker HR, van Mameren H, van Dijk PJ, et al. Skeletal muscle fibre type shifting and metabolic profile in patients with COPD. Eur Respir J 2002; 19: 617-626.
30. Gosker HR, Engelen MPKJ, van Mameren H, et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002; 76: 113-119.
31. Hesselink MK, Greenhaff PL, Constantin-Teodosiu D, et al. Increased uncoupling protein 3 content does not affect mitochondrial function in human skeletal muscle in vivo. J Clin Invest 2003; 111: 479-486.
32. Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. Br Med J Clin Res Ed 1983; 286: 1489-1493.
33. Vidal-Puig AJ, Grujic D, Zhang CY, et al. Energy metabolism in uncoupling protein 3 gene knockout mice. J Biol Chem 2000; 275: 16258-16266.
34. Engelen MP, Wouters EF, Deutz NE, Menheere PP, Schols AM. Factors contributing to alterations in skeletal muscle and plasma amino acid profiles in patients with chronic obstructive pulmonary disease. Am J Clin Nutr 2000; 72: 1480-1487.
35. Hjalmarsen A, Aasebo U, Birkeland K, Sager G, Jorde R. Impaired glucose tolerance in patients with chronic hypoxic pulmonary disease. Diabetes Metab 1996; 22: 37-42.
36. Schiffelers SL, Blaak EE, Baarends EM, et al. β-Adrenoceptor-mediated thermogenesis and lipolysis in patients with chronic obstructive pulmonary disease. Am J Physiol Endocrinol Metab 2001; 280: E357-E364.
37. Samec S, Seydoux J, Dulloo AG. Role of UCP homologues in skeletal muscles and brown adipose tissue: mediators of thermogenesis or regulators of lipids as fuel substrate? FASEB J 1998; 12: 715-724.
38. Garcia-Martinez C, Sibille B, Solanes G, et al. Overexpression of UCP3 in cultured human muscle lowers mitochondrial membrane potential, raises ATP/ADP ratio, and favors fatty acid versus glucose oxidation. FASEB J 2001; 15: 2033-2035.
39. Schrauwen P, Hesselink MK, Blaak EE, et al. Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2001; 50: 2870-2873.
40. Himms-Hagen J, Harper ME. Physiological role of UCP3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: an hypothesis. Exp Biol Med (Maywood) 2001; 226: 78-84.
41. Schrauwen P, Saris WH, Hesselink MK. An alternative function for human uncoupling protein 3: protection of mitochondria against accumulation of nonesterified fatty acids inside the mitochondrial matrix. FASEB J 2001; 15: 2497-2502.
42. Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Ant J Respir Crit Care Med 1996; 153: 288-293.
43. Pecqueur C, Couplan E, Bouillaud F, Ricquier D. Genetic and physiological analysis of the role of uncoupling proteins in human energy homeostasis. J Mol Med 2001; 79: 48-56.
44. Pouw EM, Schols AMWJ, Vusse van der GJ, Wouters EFM. Elevated inosine monophosphate levels in resting muscle of patients with stable COPD. Am J Respir Crit Care Med 1998; 157: 453-457.
45. Rahman I, Morrison D, Donaldson K, MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 1996; 154: 1055-1060.
46. Engelen MP, Schols AM, Does JD, Deutz NE, Wouters EF. Altered glutamate metabolism is associated with reduced muscle glutathione levels in patients with emphysema. Am J Respir Crit Care Med 2000; 161: 98-103.